Evidence map›Paper›PMID 31978079›Full record

Observational studyPloS one2020

An IL-18-centered inflammatory network as a biomarker for cerebral white matter injury.

Marie Altendahl, Pauline Maillard, Danielle Harvey, Devyn Cotter, Samantha Walters, Amy Wolf, Baljeet Singh, Visesha Kakarla, Ida Azizkhanian, Sunil A Sheth and 9 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. The enigma of vascular dementia: current state and emerging perspectives.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Observational
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. A cluster of blood-based protein biomarkers associated with decreased cerebral blood flow relates to future cardiovascular events in patients with cardiovascular disease.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Marie AltendahlMemory & Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, United States of America.
Pauline MaillardDepartment of Neurology and Center for Neurosciences, University of California, Davis, CA, United States of America.
Danielle HarveyDepartment of Public Health Sciences, University of California, Davis, CA, United States of America.
Devyn CotterMemory & Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, United States of America.
Samantha WaltersMemory & Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, United States of America.
Amy WolfMemory & Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, United States of America.
Baljeet SinghDepartment of Neurology and Center for Neurosciences, University of California, Davis, CA, United States of America.
Visesha KakarlaDepartment of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, United States of America.
Ida AzizkhanianSchool of Medicine, New York Medical College, Vahalla, NY, United States of America.
Sunil A ShethUniversity of Texas Health McGovern School of Medicine, Department of Neurology, Houston, TX, United States of America.
Guanxi XiaoDepartment of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, United States of America.
Emily FoxMemory & Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, United States of America.
Michelle YouMemory & Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, United States of America.
Mei LengDepartment of Medicine Statistics Core, Department of Medicine, University of California Los Angeles, Los Angeles, CA, United States of America.
David ElashoffDepartment of Medicine Statistics Core, Department of Medicine, University of California Los Angeles, Los Angeles, CA, United States of America.
Joel H KramerMemory & Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, United States of America.
Charlie DecarliDepartment of Neurology and Center for Neurosciences, University of California, Davis, CA, United States of America.
Fanny ElahiMemory & Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, United States of America.
Jason D HinmanDepartment of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, United States of America.ORCID 0000-0002-0872-5044
University of California, San Francisco · USUniversity of California, Los Angeles · USCenter for Neurosciences · USNew York Medical College · USThe University of Texas Health Science Center at Houston · USUniversity of California, Davis · US

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Serggio Carlo Lanata · 2019 to 2026
$36.9M
UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI DECARLI, CHARLES · 1991 to 2020
$28.3M
South Texas Alzheimer's Disease Research CenterP30AG066546 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Sudha Seshadri · 2021 to 2026
$24.0M
PRECURSORS OF STROKE INCIDENCE AND PROGNOSISR01NS017950 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Hugo Javier Aparicio, Jose Rafael Romero · 1985 to 2026
$22.9M
Temporal Trends, Novel Imaging and Molecular Characterization of Preclinical and Clinical Alzheimer's Disease in the Framingham CohortsR01AG054076 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI DECARLI, CHARLES, SESHADRI, SUDHA · 2016 to 2020
$12.3M
Mechanisms of Executive Decline in Normal AgingR01AG032289 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Kaitlin B Casaletto, JOEL H KRAMER · 2009 to 2026
$8.3M
Multidisciplinary Research Fellowship in Alzheimer’s disease and Related DementiasT32AG023481 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRUCE L MILLER, HOWARD J ROSEN · 2005 to 2026
$7.4M
Biological Predictors Of Brain Aging Trajectories Diversity Supplement: African American Outreach And The Intersection Between Social Determinants Of Health And Biomarkers Of Degenerative DiseaseRF1AG032289 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRAMER, JOEL H · 2020 to 2021
$5.3M
Novel imaging and endothelial biomarkers of small vessel cerebrovascular diseaseUH3NS100608 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DECARLI, CHARLES, KRAMER, JOEL H · 2018 to 2020
$3.5M
Effects of chronic inflammation on brain structure and functionR01AG048234 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRAMER, JOEL H · 2015 to 2019
$3.2M
UCLA Summer Research Training in Aging for Medical Stud*T35AG026736 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Cathy Lee, John C Newman · 2005 to 2026
$3.0M
NIA NIH HHS P01 AG019724NIA NIH HHS P30 AG010129NIA NIH HHS P30 AG062422NIA NIH HHS P30 AG066546NIA NIH HHS R01 AG032289NIA NIH HHS R01 AG048234NIA NIH HHS R01 AG054076NIA NIH HHS RF1 AG032289NIA NIH HHS T32 AG023481NIA NIH HHS T35 AG026736NIA NIH HHS U01 AG052409NINDS NIH HHS R01 NS017950NINDS NIH HHS UH2 NS100608NINDS NIH HHS UH3 NS100608
6 · The paper itself

Abstract

Chronic systemic sterile inflammation is implicated in the pathogenesis of cerebrovascular disease and white matter injury. Non-invasive blood markers for risk stratification and dissection of inflammatory molecular substrates in vivo are lacking. We sought to identify whether an interconnected network of inflammatory biomarkers centered on IL-18 and all previously associated with white matter lesions could detect overt and antecedent white matter changes in two populations at risk for cerebral small vessel disease. In a cohort of 167 older adults (mean age: 76, SD 7.1, 83 females) that completed a cognitive battery, physical examination, and blood draw in parallel with MR imaging including DTI, we measured cerebral white matter hyperintensities (WMH) and free water (FW). Concurrently, serum levels of a biologic network of inflammation molecules including MPO, GDF-15, RAGE, ST2, IL-18, and MCP-1 were measured. The ability of a log-transformed population mean-adjusted inflammatory composite score (ICS) to associate with MR variables was demonstrated in an age and total intracranial volume adjusted model. In this cohort, ICS was significantly associated with WMH (β = 0.222, p = 0.013), FW (β = 0.3, p = 0.01), and with the number of vascular risk factor diagnoses (r = 0.36, p<0.001). In a second cohort of 131 subjects presenting for the evaluation of acute neurologic deficits concerning for stroke, we used serum levels of 11 inflammatory biomarkers in an unbiased principal component analysis which identified a single factor significantly associated with WMH. This single factor was strongly correlated with the six component ICS identified in the first cohort and was associated with WMH in a generalized linear regression model adjusted for age and gender (p = 0.027) but not acute stroke. A network of inflammatory molecules driven by IL-18 is associated with overt and antecedent white matter injury resulting from cerebrovascular disease and may be a promising peripheral biomarker for vascular white matter injury.

Indexed as

AgedAged, 80 and overBiomarkersCerebral Small Vessel DiseasesCross-Sectional StudiesDiffusion Tensor ImagingFemaleHumansInterleukin-18MaleRisk AssessmentRisk FactorsSignal TransductionStrokeWhite MatterBiomarkersIL18 protein, humanInterleukin-18

Identifiers

PMID31978079
PMCPMC6980497
OpenAlexW3003088065

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.